{Reference Type}: Journal Article
{Title}: [Advances in Headache and Future Prospects].
{Author}: Nagata E;
{Journal}: Brain Nerve
{Volume}: 76
{Issue}: 8
{Year}: 2024 Aug
暂无{DOI}: 10.11477/mf.1416202709
{Abstract}: Headache is the most common condition encountered in neurological practice. However, despite the burden to patients, migraine, a typical primary headache, is not life-threatening, and evaluation shows no abnormalities; therefore, it is often treated using analgesics. Moreover, patients often do not visit hospitals and clinics because over-the-counter analgesics, such as nonsteroidal anti-inflammatory drugs are easily available. However, many patients continue to experience headaches. Migraine therapy has progressed remarkably following the advent of calcitonin gene-related peptide antibody drugs in recent years. Many patients with migraine do not visit hospitals and clinics and do not receive appropriate treatment. Therefore, in the future, neurologists will need to play a key role in patient education and in training physicians to enable accurate diagnosis of headaches.